66
Views
0
CrossRef citations to date
0
Altmetric
Review

Point-of-Care INR Measurement in Children Requiring Warfarin: What has been Evaluated and Future Directions

, &
Pages 651-659 | Published online: 29 Sep 2008

Bibliography

  • Andrew M , MarzinottoV, BrookerLAet al.: Oral anticoagulation therapy in pediatric patients: a prospective study. Thromb. Haemost.71(3), 265–269(1994).
  • Monagle P , ChanA, MassicotteP, Chalmers E, Michelson AD: Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest126(3 Suppl.), 645S–687S (2004).
  • Newall F , SavoiaH, CampbellJ, MonagleP: Anticoagulation clinics for children achieve improved warfarin management.Thromb. Res.114(1), 5–9(2004).
  • Massicotte P , MarzinottoV, VeghP, Adams M, Andrew M: Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor. J. Pediatr.127(3), 389–394(1995).
  • Segel GB , FrancisCA: Anticoagulant proteins in childhood venous and arterial thrombosis: a review. (Erratum appears inBlood Cells Mol. Dis.27(4), 781). Blood Cells Mol. Dis.26(5), 540–560(2000).
  • Christensen TD , AttermannJ, HjortdalVE, MaegaardM, HasenkamJM: Self-management of oral anticoagulation in children with congenital heart disease.Cardiology in the Young11(3), 269–276(2001).
  • Marzinotto V , MonagleP, ChanAet al.: Capillary whole blood monitoring of oral anticoagulants in children in outpatient clinics and the home setting. Pediatr. Cardiol.21(4), 347–352(2000).
  • Monagle P , ChanA, MassicotteP, Chalmers E, Michelson AD: Antithrombotic therapy in neonates and children: the Eighth ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest133(6 Suppl.), 645S–687S (2008).
  • Bauman ME , BlackKL, MassicotteMP, BaumanML, KuhleS, Howlett-ClyneSet al.: Accuracy of the CoaguChek XS™ for point-of-care international normalized ratio (INR) measurement in children requiring warfarin. Thromb. Haem.99(6), 1097–1103(2008).
  • Streif W , AndrewM, MarzinottoVet al.: Analysis of warfarin therapy in pediatric patients: a prospective cohort study of 319 patients. Blood94(9), 3007–3014(1999).
  • Barnes C , NewallF, IgnjatovicVet al.: Reduced bone density in children on long-term warfarin. Pediatric Res.57(4), 578–581(2005).
  • Ansell J , HirshJ, HylekE, JacobsonA, CrowtherM, PalaretiG: Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition).Chest133(6 Suppl. 6) (2008).
  • Hirsh J , DalenJE, AndersonDRet al.: Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest119(1 Suppl.) (2001).
  • Bauman M , BlackK, KuhleS, WangL, LeggeL, Callen-WicksDet al.: Kidclot©: the importance of validated educational intervention for optimal long term warfarin management in children. Thromb. Res. DOI:10.1016/j.thromres.2008.07.012 (2008) (Epub ahead of print).
  • Newall F , MonagleP, JohnstonL: Home INR monitoring of oral anticoagulant therapy in children using the CoaguChekS™ point-of-care monitor and a robust education program.Thromb. Res. (2006).
  • Mahonen S , RiikonenP, VaatainenRL, TikanojaT: Oral anticoagulant treatment in children based on monitoring at home.Acta Paediatr.93(5), 687–691(2004).
  • Jacobson AK : The North American experience with patient self-testing of the INR.Sem. Vasc. Med.3(3), 295–301(2003).
  • Newall F , BaumanM: Point-of-care monitoring of anticoagulant therapy in paediatric patients.Progress in Pediatric Cardiology21(1), 53–61(2005).
  • Kemme M , FaaijR, SchoemakerRet al.: Disagreement between bedside and laboratory activated partial thromboplastin time and international normalised ratio for various novel anticoagulants. Blood Coag. Fibrin.12(7), 583–591(2001).
  • Kitchen S , PrestonFE: Monitoring oral anticoagulant treatment with the TAS near-patient test system: comparison with conventional thromboplastins.J. Clin. Pathol.50(11), 951–96(1997).
  • Lutomski DM : Warfarin, short bowel syndrome, and intravenous lipids.Pharmacotherapy18(6), 1375–1376(1998).
  • Ansell J , HamkeA, HoldenA, KnapicN: Cost effectiveness of monitoring warfarin therapy using standard versus capillary prothrombin times.Am. J. Clin. Pathol.91(5), 587–589(1988).
  • Ansell J , HoldenA, KnapicN: Patient self-management of oral anticoagulation guided by capillary (fingerstick) whole blood prothrombin times.Arch. Intern. Med.149(11), 2509–2511(1989).
  • Jennings I , LuddingtonRJ, BaglinT: Evaluation of the Ciba Corning Biotrack 512 coagulation monitor for the control of oral anticoagulation.J. Clin. Pathol.44(11), 950–953(1991).
  • Lucas F , DuncanA, JayRet al.: A novel whole blood capillary technique for measuring the prothrombin time. Am. J. Clin. Pathol.88(4), 442–446(1987).
  • Bussey HI , ChiquetteE, BiancoTMet al.: A statistical and clinical evaluation of fingerstick and routine laboratory prothrombin time measurements. Pharmacotherapy17(5), 861–866(1997).
  • Douketis JD , LaneA, MilneJ, GinsbergJS: Accuracy of a portable International normalization ratio monitor in outpatients receiving long-term oral anticoagulant therapy: comparison with a laboratory reference standard using clinically relevant criteria for agreement.Thromb. Res.92(1), 11–17(1998).
  • Fitzmaurice DA , MachinSJ: British Society of Haematology Task Force for Haemostasis: recommendations for patients undertaking self management of oral anticoagulation.Br. Med. J.323(7319), 985–989(2001).
  • Lassen JF , KjeldsenJ, AntonsenS, Hyltoft PetersenP, BrandslundI: Interpretation of serial measurements of international normalized ratio for prothrombin times in monitoring oral anticoagulant therapy.Clin. Chem.41(8 Pt 1), 1171–1176(1995).
  • Ansell J , HirshJ, DalenJet al.: Managing oral anticoagulant therapy. Chest119(1 Suppl.), 22S–38S (2001).
  • Anderson DR , HarrisonL, HirshJ: Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy.Arch. Intern. Med.153(12), 1441–1447(1993).
  • Shermock KM , BraggL, ConnorJT, FinkJ, MazzoliG, Kottke-MarchantK: Differences in warfarin dosing decisions based on international normalized ratio measurements with two point-of-care testing devices and a reference laboratory measurement.Pharmacotherapy22(11), 1397–1404(2002).
  • Sabaté E : Adherence to long-term therapies: evidence for action. World Health Organization (2003).
  • Bauman ME , MassicotteMP, RayL, Newburn-CookC: Developing educational materials to facilitate adherence: pediatric thrombosis as a case illustration.J. Ped. Health Care21(3), 198–206(2007).
  • Hill J , PerreaultS, DorvalM: Validity of CoaguChek S for home monitoring of anticoagulant therapy in pediatrics.Can. J. Cardiol.23(1), 47–50(2007).
  • Nowatzke W , LandtM, SmithC, WilhiteT, CanterC, Luchtman-JonesL: Whole blood international normalization ratio measurements in children using near-patient monitors.J. Ped. Hematol./Oncol.25(1), 33–37(2003).
  • Ignjatovic V , BarnesC, NewallF, Hamilton S, Burgess J, Monagle P: Point of care monitoring of oral anticoagulant therapy in children: comparison of CoaguChek Plus™ and Thrombotest methods with venous international normalised ratio. (See comment). Thromb. Haemost.92(4), 734–737(2004).
  • Williams VK , GriffithsABM: Acceptability of CoaguChek S™ and CoaguChek XS™ generated international normalised ratios against a laboratory standard in a paediatric setting.Pathology39(6), 575–579(2007).
  • Ansell JE , HughesR: Evolving models of warfarin management: anticoagulation clinics, patient self-monitoring, and patient self-management.Am. Heart J.132(5), 1095–1100(1996).
  • Hawe P , DegelingD, HallJ: Evaluating Health Promotion: a Health Workers Guide (1st Edition). MacLellan and Petty, Sydney, Australia (1992).
  • Douketis JD : Patient self-monitoring of oral anticoagulant therapy: potential benefits and implications for clinical practice.Am. J. Cardiovasc. Drugs1(4), 245–251(2001).
  • Ansell J , JacobsonA, LevyJ, VollerH, HasenkamJM: International Self-Monitoring Association for Oral A. Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by the International Self-Monitoring Association for Oral Anticoagulation.Int. J. Cardiol.99(1), 37–45(2005).
  • Christensen TD , AndersenNT, Attermann J, Hjortdal VE, Maegaard M, Hasenkam JM: Mechanical heart valve patients can manage oral anticoagulant therapy themselves. (See comment). Eur. J. Cardiothorac. Surg.23(3), 292–298(2003).
  • Christensen TD , AttermannJ, Pilegaard HK, Andersen NT, Maegaard M, Hasenkam JM: Self-management of oral anticoagulant therapy for mechanical heart valve patients. Scand. Cardiovasc. J.35(2), 107–113(2001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.